James Rowley, MD, of Rush University System for Health, says napping for 15–20 minutes can refresh, but taking frequent naps hints at poor sleep.
The AMA collaborates on a tool to identify inequities in access, coverage and payment for mental health and substance-use services.
The AMA’s Physician Well-Being Program aims to raise awareness, advance knowledge and catalyze change to reduce burnout. Learn more with the AMA.
Find information on what the CPT code set is and why CPT codes are integral to health care innovation.
Opioids can be an effective treatment for chronic pain, but prescribing them properly requires prudence. Learn more with the AMA.
A framework for educators and administrators who create programs for coaching medical students—view videos, purchase books or download directories of workshop participants.
When writing your personal statement, veteran residency program directors said that authenticity will trump AI every time. ChatGPT agrees.
For Bo Hrom, MD, of Hattiesburg Clinic, the emotional toll of treating cancer patients is offset by the reward of improving their lives.
Most physicians practice where they completed residency, but not all. Learn which specialties and states are most likely to keep you local.
It wasn’t easy for AMA member Daniel E. Choi, MD, to start his physician private practice. He wishes he’d known that it would turn out OK. Learn more.
AMA-led federation letters oppose federal bill expanding pharmacists’ scope of practice and more in the latest National Advocacy Update.
Federal health research tackles kidney disease and more in the latest National Advocacy Update.
This two-day boot camp, Sept. 17-18, 2025, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
ChangeMedEd® is a national conference that brings together leaders and innovators to accelerate change in medical education across the continuum. Learn more.
Download and review the PDF list of pending reports from the Board and the councils, and submit comments and feedback.
Make travel arrangements for the Interim Meeting of the HOD taking place Nov. 14-18, 2025 at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
View candidates for upcoming elections for the Underrepresented in Medicine Advocacy Section (UMAS) Governing Council.
Find the agenda PDF, documents and more for the 2025 APS Interim Meeting on Nov. 13 at the Gaylord National Resort & Convention Center, National Harbor, Maryland.
In the news: Measles cases surge in the Americas, COVID accelerates vascular aging and more.
From alopecia areata to seborrheic dermatitis, these patient-friendly tools make it easier for you to explain dermatological conditions.
The opioid epidemic affects the lives of millions of Americans. Find out how the AMA is leading the fight against opioid addiction in America.
Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.
Access to medication treatment in correctional facilities is not only protected by the law, but it is essential.
The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.
Sterile needle and syringe exchange bill headed to Arizona governor and more in the latest State Advocacy Update.
Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.
New program covering the cost of administering COVID-19 vaccines and more in the latest National Advocacy Update.
Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.
AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
The CDC is reporting a record-breaking annual toll of nearly 90,000 U.S. overdose deaths. Learn about the policy steps needed to stem the tide.
